Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 428

1.

Oxybutynin for Hot Flashes Due to Androgen Deprivation in Men.

Smith TJ, Loprinzi CL, Deville C.

N Engl J Med. 2018 May 3;378(18):1745-1746. doi: 10.1056/NEJMc1801992. No abstract available.

3.

Cutaneous granulomas caused by subcutaneous injections of leuprorelin acetate.

Kluger N, Hahtola S, Lempinen T, Jeskanen L.

Presse Med. 2017 Oct;46(10):966-968. doi: 10.1016/j.lpm.2017.08.004. Epub 2017 Sep 14. No abstract available.

PMID:
28919272
4.

Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study.

Hashizume A, Katsuno M, Suzuki K, Hirakawa A, Hijikata Y, Yamada S, Inagaki T, Banno H, Sobue G.

J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1026-1032. doi: 10.1136/jnnp-2017-316015. Epub 2017 Aug 5.

PMID:
28780536
5.

Progesterone receptor modulators for endometriosis.

Fu J, Song H, Zhou M, Zhu H, Wang Y, Chen H, Huang W.

Cochrane Database Syst Rev. 2017 Jul 25;7:CD009881. doi: 10.1002/14651858.CD009881.pub2. Review.

PMID:
28742263
6.

Pituitary apoplexy: a rare complication of leuprolide therapy in prostate cancer treatment.

Tanios G, Mungo NA, Kapila A, Bajaj K.

BMJ Case Rep. 2017 Jul 14;2017. pii: bcr-2016-218514. doi: 10.1136/bcr-2016-218514.

PMID:
28710301
7.

Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney.

Pereira N, Lekovich JP, Kligman I, Rosenwaks Z.

Gynecol Endocrinol. 2017 Aug;33(8):593-597. doi: 10.1080/09513590.2017.1318372. Epub 2017 Apr 25.

PMID:
28440686
8.

[Cost effectiveness of GnRH antagonists in patients with prostate cancer and cardiovascular risk : Comparative analysis against Leuprorelin by the Number Needed to Treat].

Anderson D, Lehmann J, Ecker T, Vosgerau S, Donatz V.

Urologe A. 2017 Jul;56(7):917-924. doi: 10.1007/s00120-017-0382-8. German. Erratum in: Urologe A. 2017 Jun 19;:.

PMID:
28405705
9.

Psychotic Exacerbation Following Subcutaneous Leuprolide in a Male Patient With Previous History of Schizophrenia.

Mitchell BG, Adams AL, Thandi PK.

Prim Care Companion CNS Disord. 2017 Apr 6;19(2). doi: 10.4088/PCC.16l02038. No abstract available.

10.

Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial.

Liu C, Lu Q, Qu H, Geng L, Bian M, Huang M, Wang H, Zhang Y, Wen Z, Zheng S, Zhang Z.

Medicine (Baltimore). 2017 Feb;96(7):e6124. doi: 10.1097/MD.0000000000006124.

11.

Effects of ovarian ablation or suppression in premenopausal breast cancer: A meta-analysis of randomized controlled trials.

Zhang P, Li CZ, Jiao GM, Zhang JJ, Zhao HP, Yan F, Jia SF, Hu BS, Wu CT.

Eur J Surg Oncol. 2017 Jul;43(7):1161-1172. doi: 10.1016/j.ejso.2016.11.011. Epub 2016 Dec 5. Review.

PMID:
28024943
13.

Autoimmune estrogen dermatitis in an infertile female.

Elcin G, Gülseren D, Bayraktar M, Gunalp S, Gurgan T.

Cutan Ocul Toxicol. 2017 Jun;36(2):195-198. doi: 10.1080/15569527.2016.1245197. Epub 2016 Nov 2.

PMID:
27723997
14.
15.

[Urolithiasis in the Long-Term GnRH Agonist Treatment of Patients with Paraphilia: 3 Case Studies].

Mayrhofer G, Wegner D, Voß T.

Aktuelle Urol. 2016 Dec;47(6):487-490. doi: 10.1055/s-0042-112999. Epub 2016 Oct 4. German.

PMID:
27701680
16.

Pituitary Apoplexy After Initial Leuprolide Injection.

Fabiano AJ, George S.

World Neurosurg. 2016 Nov;95:616.e7-616.e9. doi: 10.1016/j.wneu.2016.08.091. Epub 2016 Aug 29.

PMID:
27586180
17.

Adverse Health Effects of Intermittent vs Continuous Androgen Deprivation Therapy for Metastatic Prostate Cancer: Relating 33 Years of Patient Clinical Care.

Strum SB, Scholz MC.

JAMA Oncol. 2016 May 1;2(5):686. doi: 10.1001/jamaoncol.2016.0367. No abstract available.

PMID:
27244678
18.

Low-dose add-back therapy during postoperative GnRH agonist treatment.

Tsai HW, Wang PH, Huang BS, Twu NF, Yen MS, Chen YJ.

Taiwan J Obstet Gynecol. 2016 Feb;55(1):55-9. doi: 10.1016/j.tjog.2015.04.004.

19.

Differences in Hypercholesterolemia and Atherogenesis Induced by Common Androgen Deprivation Therapies in Male Mice.

Poulsen CB, Mortensen MB, Koechling W, Sørensen CB, Bentzon JF.

J Am Heart Assoc. 2016 Feb 23;5(2). pii: e002800. doi: 10.1161/JAHA.115.002800.

20.

Sex differences in visuospatial abilities persist during induced hypogonadism.

Guerrieri GM, Wakim PG, Keenan PA, Schenkel LA, Berlin K, Gibson CJ, Rubinow DR, Schmidt PJ.

Neuropsychologia. 2016 Jan 29;81:219-29. doi: 10.1016/j.neuropsychologia.2015.12.021. Epub 2015 Dec 21.

Supplemental Content

Loading ...
Support Center